Search Results - "Aguilo, Maria Antonia Alberti"
-
1
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
Published in Muscle & nerve (01-07-2019)“…ABSTRACT Introduction: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody‐positive refractory generalized…”
Get full text
Journal Article -
2
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
Published in Neurology (26-01-2021)“…To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the…”
Get full text
Journal Article -
3
Eculizumab improves fatigue in refractory generalized myasthenia gravis
Published in Quality of life research (01-08-2019)“…Purpose To evaluate the effect of eculizumab on perceived fatigue in patients with anti-acetylcholine receptor antibody-positive, refractory, generalized…”
Get full text
Journal Article -
4
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
Published in Journal of the neurological sciences (15-12-2019)“…The terminal complement inhibitor eculizumab was shown to improve myasthenia gravis-related symptoms in the 26-week, phase 3, randomized, double-blind,…”
Get full text
Journal Article -
5
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis
Published in Quality of life research (01-08-2019)“…The article “Eculizumab improves fatigue in refractory generalized myasthenia gravis”, written by “Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny…”
Get full text
Journal Article -
6
Myasthenia gravis exacerbation after cetirizine administration
Published in Muscle & nerve (01-07-2011)Get full text
Journal Article -
7
Intravenous versus subcutaneous immunoglobulin – Authors' reply
Published in Lancet neurology (01-05-2018)“…In the ICE trial (intravenous immune globulin [10% caprylate-chromatography purified] for the treatment of CIPD),2 the absolute risk reduction for relapse with…”
Get full text
Journal Article -
8
Myasthenia gravis exacerbation after cetirizine administration
Published in Muscle & nerve (01-07-2011)Get full text
Report